Randall H Gholson

Array ( [id] => 3864097 [patent_doc_number] => 05762934 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Clostridium difficile toxin disease therapy' [patent_app_type] => 1 [patent_app_number] => 8/456847 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 27210 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/762/05762934.pdf [firstpage_image] =>[orig_patent_app_number] => 456847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3655368 [patent_doc_number] => 05622837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Pancreas elastase 1-specific antibody, a process for obtaining it, and a test kit containing such antibody' [patent_app_type] => 1 [patent_app_number] => 8/457172 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3189 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622837.pdf [firstpage_image] =>[orig_patent_app_number] => 457172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831311 [patent_doc_number] => 05814477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Recombinant clostridial toxin protein' [patent_app_type] => 1 [patent_app_number] => 8/457048 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 27214 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814477.pdf [firstpage_image] =>[orig_patent_app_number] => 457048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730303 [patent_doc_number] => 05670628 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Radio-labelling of proteins' [patent_app_type] => 1 [patent_app_number] => 8/455893 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4428 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670628.pdf [firstpage_image] =>[orig_patent_app_number] => 455893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4066464 [patent_doc_number] => 05866692 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Process for producing humanized chimera antibody' [patent_app_type] => 1 [patent_app_number] => 8/454680 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 38 [patent_no_of_words] => 21419 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866692.pdf [firstpage_image] =>[orig_patent_app_number] => 454680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768368 [patent_doc_number] => 05807548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Method of treating cancer using a chimera antibody' [patent_app_type] => 1 [patent_app_number] => 8/454683 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 38 [patent_no_of_words] => 21497 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807548.pdf [firstpage_image] =>[orig_patent_app_number] => 454683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690480 [patent_doc_number] => 05604126 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'Murine hybridoma 4A11 and diagnostic antibody produced thereby' [patent_app_type] => 1 [patent_app_number] => 8/453582 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5388 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/604/05604126.pdf [firstpage_image] =>[orig_patent_app_number] => 453582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619045 [patent_doc_number] => 05601825 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Therapeutic conjugates of toxins and drugs' [patent_app_type] => 1 [patent_app_number] => 8/452131 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5202 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/601/05601825.pdf [firstpage_image] =>[orig_patent_app_number] => 452131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685716 [patent_doc_number] => 05695952 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Method for producing ›Leu.sup.13 !motilin' [patent_app_type] => 1 [patent_app_number] => 8/450384 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 14772 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695952.pdf [firstpage_image] =>[orig_patent_app_number] => 450384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3929646 [patent_doc_number] => 05877293 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'CDR grafted anti-CEA antibodies and their production' [patent_app_type] => 1 [patent_app_number] => 8/449287 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 19 [patent_no_of_words] => 11487 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877293.pdf [firstpage_image] =>[orig_patent_app_number] => 449287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3630759 [patent_doc_number] => 05686579 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Use of antibody/antigen interactions to protect biologically active proteins and peptides' [patent_app_type] => 1 [patent_app_number] => 8/447422 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11831 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686579.pdf [firstpage_image] =>[orig_patent_app_number] => 447422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3631025 [patent_doc_number] => 05686600 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Antibodies which bind to insect gut proteins and their use' [patent_app_type] => 1 [patent_app_number] => 8/442542 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13797 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686600.pdf [firstpage_image] =>[orig_patent_app_number] => 442542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3727213 [patent_doc_number] => 05665380 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Lipid vesicle fusion as a method of transmitting a biologically active material to a cell' [patent_app_type] => 1 [patent_app_number] => 8/420324 [patent_app_country] => US [patent_app_date] => 1995-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9593 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665380.pdf [firstpage_image] =>[orig_patent_app_number] => 420324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781212 [patent_doc_number] => 05736119 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates' [patent_app_type] => 1 [patent_app_number] => 8/409960 [patent_app_country] => US [patent_app_date] => 1995-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8488 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736119.pdf [firstpage_image] =>[orig_patent_app_number] => 409960 [rel_patent_id] =>[rel_patent_doc_number] =>)